Ngā hua rapu kaituhi

1

Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? mā Gwo–Tzer Ho

I whakaputaina 2003

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases mā Duncan Rutherford, Gwo–Tzer Ho

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention mā Gwo–Tzer Ho, Arianne L. Theiss

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Pathogenesis of Crohn's disease mā Ray Boyapati, Jack Satsangi, Gwo–Tzer Ho

I whakaputaina 2015

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Ulcerative colitis: Recent advances in the understanding of disease pathogenesis mā Ross J Porter, Rahul Kalla, Gwo–Tzer Ho

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Pré-impressão

Tiaki ki tētahi rārangi

I tiakina i:
6

Biomarkers in Search of Precision Medicine in IBD mā Ray Boyapati, Rahul Kalla, Jack Satsangi, Gwo–Tzer Ho

I whakaputaina 2016

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications mā Ray Boyapati, Adriano G. Rossi, Jack Satsangi, Gwo–Tzer Ho

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases mā Ray Boyapati, Arina Tamborska, David A. Dorward, Gwo–Tzer Ho

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Pré-impressão

Tiaki ki tētahi rārangi

I tiakina i:
9

Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation mā Broc Drury, Gareth Hardisty, Robert D. Gray, Gwo–Tzer Ho

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing mā Gwo–Tzer Ho, Jennifer A. Cartwright, Emily Thompson, Calum C. Bain, Adriano G. Rossi

I whakaputaina 2020

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort mā Gwo–Tzer Ho, Paul T.L. Chiam, Hazel E. Drummond, Joseph Loane, Ian Arnott, Jack Satsangi

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Genetics of the innate immune response in inflammatory bowel disease mā Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Gwo–Tzer Ho, Ian Arnott, David C. Wilson, Jack Satsangi

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis mā Gwo–Tzer Ho, Elaine R. Nimmo, Albert Tenesa, Janice Fennell, Hazel E. Drummond, Craig Mowat, I. Arnott, Jack Satsangi

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

The Contribution of OCTN1/2 Variants Within the IBD5 Locus to Disease Susceptibility and Severity in Crohn’s Disease mā Colin Noble, Elaine R. Nimmo, Hazel E. Drummond, Gwo–Tzer Ho, Albert Tenesa, Linda Smith, Norman F. Anderson, Ian Arnott, Jack Satsangi

I whakaputaina 2005

Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
15

$The use of adalimumab in the management of refractory Crohn’s disease$

The use of adalimumab in the management of refractory Crohn’s disease mā Gwo–Tzer Ho, Lesley Smith, Susan C. Aitken, H. M. Lee, Terence Ting, J. Fennell, Charlie W. Lees, K Palmér, Ian Penman, Alan G. Shand, Ian Arnott, Jack Satsangi

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Mitochondrial DNA Is a Pro-Inflammatory Damage-Associated Molecular Pattern Released During Active IBD mā Ray Boyapati, David A. Dorward, Arina Tamborska, Rahul Kalla, Nicholas T. Ventham, Mary K. Doherty, Philip D. Whitfield, Mohini Gray, Joseph Loane, Adriano G. Rossi, Jack Satsangi, Gwo–Tzer Ho

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases mā Rahul Kalla, Nicholas A. Kennedy, Nicholas T. Ventham, Ray Boyapati, Alex Adams, Elaine R. Nimmo, Micaela Rios Visconti, Hazel E. Drummond, Gwo–Tzer Ho, Rebecca Pattenden, David C. Wilson, Jack Satsangi

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Purine metabolism controls innate lymphoid cell function and protects against intestinal injury mā Siobhan Crittenden, Ashleigh Cheyne, Alex Adams, Thorsten Forster, Calum T. Robb, Jennifer M. Felton, Gwo–Tzer Ho, Dominik Rückerl, Adriano G. Rossi, Stephen M. Anderton, Peter Ghazal, Jack Satsangi, Sarah Howie, Chengcan Yao

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology mā Gareth‐Rhys Jones, Mathew Lyons, Nikolas Plevris, Philip Jenkinson, Cathy Bisset, Christopher Burgess, Shahida Din, James Fulforth, Paul Henderson, Gwo–Tzer Ho, Kathryn Kirkwood, Colin Noble, Alan G. Shand, David C. Wilson, Ian Arnott, Charlie W. Lees

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation mā Gwo–Tzer Ho, Rhona Aird, B Liu, Ray Boyapati, Nicholas A. Kennedy, David A. Dorward, Colin Noble, Takahiko Shimizu, Roderick N. Carter, Etienne Chew, Nicholas M. Morton, Adriano G. Rossi, R. Balfour Sartor, John P. Iredale, Jack Satsangi

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Gwo–Tzer Ho

Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? mā Gwo–Tzer Ho

Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases mā Duncan Rutherford, Gwo–Tzer Ho

Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention mā Gwo–Tzer Ho, Arianne L. Theiss

Pathogenesis of Crohn's disease mā Ray Boyapati, Jack Satsangi, Gwo–Tzer Ho

Ulcerative colitis: Recent advances in the understanding of disease pathogenesis mā Ross J Porter, Rahul Kalla, Gwo–Tzer Ho

Biomarkers in Search of Precision Medicine in IBD mā Ray Boyapati, Rahul Kalla, Jack Satsangi, Gwo–Tzer Ho

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications mā Ray Boyapati, Adriano G. Rossi, Jack Satsangi, Gwo–Tzer Ho

Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases mā Ray Boyapati, Arina Tamborska, David A. Dorward, Gwo–Tzer Ho

Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation mā Broc Drury, Gareth Hardisty, Robert D. Gray, Gwo–Tzer Ho

Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing mā Gwo–Tzer Ho, Jennifer A. Cartwright, Emily Thompson, Calum C. Bain, Adriano G. Rossi

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort mā Gwo–Tzer Ho, Paul T.L. Chiam, Hazel E. Drummond, Joseph Loane, Ian Arnott, Jack Satsangi

Genetics of the innate immune response in inflammatory bowel disease mā Johan Van Limbergen, Richard K. Russell, Elaine R. Nimmo, Gwo–Tzer Ho, Ian Arnott, David C. Wilson, Jack Satsangi

Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis mā Gwo–Tzer Ho, Elaine R. Nimmo, Albert Tenesa, Janice Fennell, Hazel E. Drummond, Craig Mowat, I. Arnott, Jack Satsangi

The Contribution of OCTN1/2 Variants Within the IBD5 Locus to Disease Susceptibility and Severity in Crohn’s Disease mā Colin Noble, Elaine R. Nimmo, Hazel E. Drummond, Gwo–Tzer Ho, Albert Tenesa, Linda Smith, Norman F. Anderson, Ian Arnott, Jack Satsangi

The use of adalimumab in the management of refractory Crohn’s disease mā Gwo–Tzer Ho, Lesley Smith, Susan C. Aitken, H. M. Lee, Terence Ting, J. Fennell, Charlie W. Lees, K Palmér, Ian Penman, Alan G. Shand, Ian Arnott, Jack Satsangi

Ngā utauta rapu:

Ngā marau whai pānga